EYES (Vision Twenty-One, Inc.) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EYES (Vision Twenty-One, Inc.)

EYES 4.140

-5.0%

Aug 30 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SRS who wrote (47)	5/11/1998 11:42:00 AM
From: 007	Read Replies (1) of 129

Thanks SRS, I think there is a good chance that the debt burden was underestimated, however all of their acquisitions remain immediately accretive to earnings. The question now is whether their earnings this year will be in the low .70s or in the low .60s. Coming from a loss of .03 last year, this first quarter's .11 and annual projections in the low .60s are still excellent. With revenue gaining ground even quicker, this stock is an even better value for its price to sales ratio. Furthermore, AFIK they really dominate this small but rapidly growing niche. Most see the secondaries as a negative, but after each offering their earnings per share rise due to acquisitions. However, if they can't communicate effectively to investors and analysts, then it will continue to underperform. I'm beginning to agree with Goordo about that. 007

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next